Skye Bioscience, Inc. (SKYE): Shares Outstanding
33.38M
As of 2025-12-31
35.14M
As of 2026-06-30
+109.0%
3-year compound annual growth
-35.0%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 33.38M | +7.8% | 2026-03-10, Balance as of period end |
| 2024-12-31 | 30.97M | +150.8% | 2026-03-10, Balance as of period end |
| 2023-12-31 | 12.35M | +238.0% | 2025-03-20, Balance as of period end |
| 2022-12-31 | 3.65M | -99.2% | 2024-03-22, Balance as of period end |
| 2021-12-31 | 476.11M | +65.3% | 2023-03-31, Balance as of period end |
| 2020-12-31 | 288.07M | +57.5% | 2022-03-28, Balance as of period end |
| 2019-12-31 | 182.90M | +36.6% | 2021-03-02, Balance as of period end |
| 2018-12-31 | 133.91M | n/c | 2020-03-23, Balance as of period end |
| 2017-12-31 | 33.62M | n/c | 2019-03-14, Balance as of period end |
| 2016-12-31 | 21.56M | +8.3% | 2018-03-19, Balance as of period end |
| 2015-12-31 | 19.90M | +24.4% | 2017-03-10, Balance as of period end |
| 2014-12-31 | 16.00M | n/c | 2016-03-21, Balance as of period end |
| 2013-12-31 | 7.77M | n/a | 2015-03-27, Balance as of period end |
| 2013-10-31 | 3.62M | +43.4% | 2014-01-27, Balance as of period end |
| 2012-10-31 | 2.53M | n/a | 2014-01-27, Balance as of period end |